Investigation Reveals Safety Lapses and Regulatory Failures in Fatal Cough Syrup Contamination Case

Nov 21, 2025 04:14 pm CST

An exclusive investigation into the deaths of 24 children from contaminated cough syrup has uncovered serious safety breaches in India's pharmaceutical supply chain. The report details how improper handling of propylene glycol solvent, unauthorized repackaging by unlicensed distributors, and inadequate regulatory oversight may have allowed toxic diethylene glycol to contaminate Coldrif cough syrup, raising new concerns about quality control in India's $50 billion pharmaceutical industry.